The relationship between the drug concentration profiles in plasma and the drug doses in the colon

Chemical and Pharmaceutical Bulletin

Volumn 58, Issue 10, 2010, Pages 1295-1300

  Tajiri, Shinichiro ^a   Kanamaru, Taro ^a   Yoshida, Kazuhiro ^a   Hosoi, Yasue ^a   Konno, Tsutomu ^a   Yada, Shuichi ^a   Nakagami, Hiroaki ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

Chytochrome P450 mediated metabolism; Colonic absorption; Dog; Endoscopy; Extended release dosage form

Indexed keywords

CEVIMELINE; DICLOFENAC; DILTIAZEM; FEXOFENADINE; METFORMIN; VERAPAMIL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COLON ABSORPTION; DOG; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG METABOLISM; MALE; NONHUMAN;

ADMINISTRATION, ORAL; ANIMALS; ANTI-ALLERGIC AGENTS; ANTI-ARRHYTHMIA AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIHYPERTENSIVE AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; COLON; DELAYED-ACTION PREPARATIONS; DICLOFENAC; DILTIAZEM; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOGLYCEMIC AGENTS; METFORMIN; MUSCARINIC AGONISTS; QUINUCLIDINES; TERFENADINE; THIOPHENES; VERAPAMIL;

EID: 77957659785     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.58.1295     Document Type: Article

References (40)

1. Stevens H. N. E., Speakman M., Curr. Med. Res. Opin., 22, 2323-2328 (2006).
2. Nakamura K., Nara E., Akiyama Y., J. Controlled Release, 111, 309-315 (2006).
3. Tubic M., Wagner D., Spahn-Langguth H., Weiler C., Wanitschke R., Böcher W. O., Langguth P., Eur. J. Pharm. Sci., 29, 231-239 (2006).
4. Khosla R., Davis S. S., Int. J. Pharm., 52, 1-10 (1989).
5. Coupe A. J., Davis S. S., Wilding I. R., Pharm. Res., 8, 360-364 (1991).
6. Wilding I. R., Davis S. S., Steed K. P., Sparrow R. A., Westrup J., Hempenstall J. M., Int. J. Pharm., 101, 263-268 (1994).
7. Adkin D. A., Davis S. S., Sparrow R. A., Huckle P. D., Phillips A. J., Wilding I. R., Br. J. Clin. Pharmacol., 39, 381-387 (1995).
8. Gupta V. K., Beckert T. E., Price J. C., Int. J. Pharm., 213, 83-91 (2001).
9. Adkin D. A., Davis S. S., Sparrow R. A., Wilding I. R., J. Controlled Release, 23, 147-156 (1993).
10. Hastewell J., Antonin K. H., Fox R., Mackay M., Int. J. Pharm., 126, 245-251 (1995).
11. Drewe J., Narjes H., Heinzel G., Brickl R.-S., Rohr A., Beglinger C., Br. J. Clin. Pharmacol., 50, 69-72 (2000).
12. Wu Y., Loper A., Landis E., Hettrick L., Novak L., Lynn K., Chen C., Thompson K., Higgins R., Batra U., Shelukar S., Kwei G., Storey D., Int. J. Pharm., 285, 135-146 (2004).
13. Venkatesan N., Yoshimitsu J., Ohashi Y., Ito Y., Sugioka N., Shibata N., Takada K., Int. J. Pharm., 310, 46-52 (2006).
14. McInnes F., Clear N., Humphrey M., Stevens H. N. E., Pharm. Res., 25, 1075-1084 (2008).
15. Lee Y. H., Leesman G. D., Makhey V., Yu H., Hu P., Perry B., Sutyak J. P., Wagner E. J., Falzone L. M., Stern W., Sinko P. J., Eur. J. Pharm. Biopharm., 50, 205-211 (2000).
16. Sutton S. C., Evans L. A., Fortner J. H., McCarthy J. M., Sweeney K., Pharm. Res., 23, 1554-1563 (2006).
17. Harrison A., Betts A., Fenner K., Beaumont K., Edgington A., Roffey S., Davis J., Comby P., Morgan P., Drug Metab. Dispos., 32, 197-204 (2004).
18. Kim M. K., Han L., Choi M. K., Han Y.-H., Kim D.-D., Chung S.-J., Shim C.-K., J. Pharm. Sci., 94, 2644-2655 (2005).
19. Wu C.-Y., Benet L. Z., Pharm. Res., 22, 11-23 (2005).
20. Washio T., Kohsaka K., Arisawa H., Masunaga H., Arzneimittel Forschung Drug Research, 53, 26-33 (2003).
21. Gleiter C. H., Antonin K.-H., Bieck P., Godbillon J., Schönleber W., Malchow H., Gastrointest. Endosc., 53, 71-73 (1985).
22. Sagara K., Nagamatsu Y., Yamada I., Kawata M., Mizuta H., Ogawa K., Chem. Pharm. Bull., 40, 3303-3306 (1992).
23. Ho H. O., Liu C. H., Lin H. M., Sheu M. T., J. Controlled Release, 49, 149-156 (1997).
24. Vidon N., Chaussade S., Noel M., Franchisseur C., Huchet B., Bernier J. J., Diabetes Res. Clin. Pract., 4, 223-229 (1988).
25. Marathe P. H., Wen Y., Norton J., Greene D. S., Barbhaiya R. H., Wilding I. R., Br. J. Clin. Pharmacol., 50, 325-332 (2000).
26. Tajiri S., Kanamaru T., Makoto K., Konno T., Nakagami H., Int. J. Pharm., 383, 99-105 (2010).
27. Wilding I. R., Davis S. S., Sparrow R. A., Ziemniak J. A., Heald D. L., J. Controlled Release, 33, 89-97 (1995).
28. Soldner A., Christians U., Susanto M., Wacher V. J., Silverman J. A., Benet L. Z., Pharm. Res., 16, 478-485 (1999).
29. Lemma G. L., Wang Z., Hamman M. A., Zaheer N. A., Gorski J. C., Hall S. D., Clin. Pharmacol. Ther., 79, 218-230 (2006).
30. Choi D.-H., Chung J.-H., Choi J.-S., Eur. J. Clin. Pharmacol., 66, 285-290 (2010).
31. Gervot L., Carrière V., Coate P., Cugnenc P.-H., Environ. Toxicol. Pharmacol., 2, 381-388 (1996).
32. Canaparo R., Nordmark A., Finnström N., Lundgren S., Seidegård J., Jeppsson B., Edwards R. J., Boobis A. R., Rane A., Basic Clin. Pharmcol. Toxcol., 100, 240-248 (2006).
33. Gropp F. N. C., Greger D. L., Morel C., Sauter S., Blum J. W., J. Animal Sci., 84, 2684-2691 (2006).
34. Paine M. F., Khalighi M., Fisher E. M., Shen D. D., Kunze K. L., Marsh C. L., Perkins J. D., Thummel K. E., J. Pharmacol. Exp. Ther., 283, 1552-1562 (1997).
35. Brady J. M., Cherrington N. J., Hartley D. P., Buist S. C., Li N., Klaassen C. D., Drug Metab. Dispos., 30, 838-844 (2002).
36. Thörn M., Finnström N., Lundgren S., Rane A., Lööf L., Br. J. Clin. Pharmacol., 60, 54-60 (2005).
37. Cvetkovic M. L., Leake B., Fromm M. F., Wilkinson G. R., Kim R. B., Drug Metab. Dispos., 27, 866-871 (1999).
38. Hamman M. A., Bruce M. A., Haehner-Daniels B. D., Hall S. D., Clin. Pharmacol. Ther., 69, 114-121 (2001).
39. Jones T. E., Morris R. G., Clin. Pharmacokinet., 41, 381-388 (2002).
40. Jerling M., Huan B. L., Leung K., Chu N., Abdallah H., Hussein Z., J. Clin. Pharmacol., 45, 422-433 (2005).